Antigen‐Presenting Hybrid Colloidal Crystal Clusters for Promoting T cells Expansion

Abstract T cell based‐immunotherapy has been a powerful strategy to eradicate tumor cells in clinical trials. Effectively expanding the therapeutic T cells for clinical demand is still a challenge. Here, artificial antigen‐presenting scaffolds are created for T cell ex vivo expansion. The antigen‐presenting hybrid colloidal crystal clusters (HCCCs) with multiple stimuli are generated by internal encapsulation with prosurvival cytokines and surface decoration with activating antibodies to CD3ε and CD28, respectively. With the large loading capacity endowed by their abundant nanoporous structures, the antigen‐presenting HCCCs can constantly release prosurvival cytokine IL‐2. It is found that following the direct and multiple stimulations, the antigen‐presenting HCCCs can effectively promote the expansion of T cells, which exhibits robust antitumor activity in vitro. Thus, the antigen‐presenting HCCCs provide a novel expansion platform for clinical manufacturing of T cells.